1 - 1 |
Editorial [Anonymous] |
2 - 13 |
Biodiversity loss and COVID-19 pandemic: The role of bats in the origin and the spreading of the disease Platto S, Zhou JF, Wang YQ, Wang H, Carafoli E |
14 - 23 |
History of the COVID-19 pandemic: Origin, explosion, worldwide spreading Platto S, Wang YQ, Zhou JF, Carafoli E |
24 - 34 |
A nidovirus perspective on SARS-CoV-2 Gulyaeva AA, Gorbalenya AE |
35 - 39 |
Host-directed editing of the SARS-CoV-2 genome Mourier T, Sadykov M, Carr MJ, Gonzalez G, Hall WW, Pain A |
40 - 46 |
Diamond Light Source: contributions to SARS-CoV-2 biology and therapeutics Walsh MA, Grimes JM, Stuart DI |
47 - 53 |
RNA-dependent RNA polymerase: Structure, mechanism, and drug discovery for COVID-19 Jiang Y, Yin WC, Xu HE |
54 - 62 |
High-resolution structure and biophysical characterization of the nucleocapsid phosphoprotein dimerization domain from the Covid-19 severe acute respiratory syndrome coronavirus 2 Zinzula L, Basquin J, Bohn S, Beck F, Klumpe S, Pfeifer G, Nagy I, Bracher A, Hartl FU, Baumeister W |
63 - 71 |
The main protease and RNA-dependent RNA polymerase are two prime targets for SARS-CoV-2 Jin ZM, Wang HF, Duan YK, Yang HT |
72 - 79 |
Molecular docking of potential SARS-CoV-2 papain-like protease inhibitors Li DQ, Luan JW, Zhang LL |
80 - 87 |
The biogenesis of SARS-CoV-2 spike glycoprotein: multiple targets for host-directed antiviral therapy Santopolo S, Riccio A, Santoro MG |
88 - 91 |
Evolution patterns of SARS-CoV-2: Snapshot on its genome variants Giovanetti M, Benedetti F, Campisi G, Ciccozzi A, Fabris S, Ceccarelli G, Tambone V, Caruso A, Angeletti S, Zella D, Ciccozzi M |
92 - 96 |
Obesity alters Ace2 and Tmprss2 expression in lung, trachea, and esophagus in a sex-dependent manner: Implications for COVID-19 Sarver DC, Wong GW |
97 - 103 |
Evolutionary and structural analysis elucidates mutations on SARS-CoV2 spike protein with altered human ACE2 binding affinity Chakraborty S |
104 - 107 |
The D614G mutations in the SARS-CoV-2 spike protein: Implications for viral infectivity, disease severity and vaccine design Groves DC, Rowland-Jones SL, Angyal A |
108 - 115 |
Functional importance of the D614G mutation in the SARS-CoV-2 spike protein Jackson CB, Zhang LZ, Farzan M, Choe H |
116 - 124 |
Lost in deletion: The enigmatic ORF8 protein of SARS-CoV-2 Zinzula L |
125 - 131 |
COVID19-clinical presentation and therapeutic considerations Kenny G, Mallon PW |
132 - 136 |
Leveraging coronavirus binding to gangliosides for innovative vaccine and therapeutic strategies against COVID-19 Fantini J, Chahinian H, Yahi N |
137 - 144 |
Identifying and repurposing antiviral drugs against severe acute respiratory syndrome coronavirus 2 with in silico and in vitro approaches Watashi K |
145 - 150 |
Remdesivir: From Ebola to COVID-19 Santoro MG, Carafoli E |
151 - 155 |
Immunomodulation for the management of severe SARS-CoV2 infections. State of the art and review of the literature Bacca E, Digaetano M, Meschiari M, Franceschini E, Menozzi M, Cuomo G, Mussini C |
156 - 162 |
Chloroquine and hydroxychloroquine in the prophylaxis and therapy of COVID-19 infection Carafoli E |
173 - 179 |
Identification of antiviral antihistamines for COVID-19 repurposing Reznikov LR, Norris MH, Vashisht R, Bluhm AP, Li DM, Liao YSJ, Brown A, Butte AJ, Ostrov DA |
180 - 186 |
Comprehensive analysis of COVID-19 during pregnancy Moore KM, Suthar MS |
187 - 191 |
Humoral immune responses and neutralizing antibodies against SARS-CoV-2; implications in pathogenesis and protective immunity Carrillo J, Izquierdo-Useros N, Avila-Nieto C, Pradenas E, Clotet B, Blanco J |
192 - 203 |
Recognition of the SARS-CoV-2 receptor binding domain by neutralizing antibodies Yuan M, Liu HJ, Wu NIC, Wilson IA |
204 - 210 |
T-cell dysregulation in COVID-19 Kalfaoglu B, Almeida-Santos J, Tye CA, Satou Y, Ono M |
211 - 217 |
T cell immunity to SARS-CoV-2 following natural infection and vaccination DiPiazza AT, Graham BS, Ruckwardt TJ |
218 - 220 |
Vaccine-induced protection in aging adults and pandemic response Schenkelberg T |
221 - 225 |
Identifying SARS-CoV-2 infections in South Africa: Balancing public health imperatives with saving lives Baxter C, Karim QA, Karim SSA |
226 - 230 |
Laboratory testing for the diagnosis of COVID-19 Lai CKC, Lam W |
231 - 237 |
Application technology to fi ght the COVID-19 pandemic: Lessons learned in Thailand Intawong K, Olson D, Chariyalertsak S |
238 - 243 |
Proactive and blended approach for COVID-19 control in Taiwan Cheng HY, Huang ASE |
244 - 252 |
A perspective on early detection systems models for COVID-19 spreading Vianello C, Strozzi F, Mocellin P, Cimetta E, Fabiano B, Manenti F, Pozzi R, Maschio G |
253 - 258 |
Range of reproduction number estimates for COVID-19 spread Pasetto D, Lemaitre JC, Bertuzzo E, Gatto M, Rinaldo A |